bullish
IDT Australia (IDT): Poised to Benefit from RNA and On-Shoring
DT Australia has a long track record as a manufacturer of pharmaceutical drugs, including both active pharmaceutical ingredients (API) and finished drug products at its facilities in Melbourne.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 23-minute read)
Discussions
(Paid Plans Only)
x